Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma

Abstract

Elevated <i>MPP6</i> expression is associated with an unfavorable prognosis, angiogenesis and immune evasion in HCC. Moreover, <i>MPP6</i> has the potential to be used to assess TMB and treatment response. Therefore, <i>MPP6</i> might serve as a novel prognostic biomarker and therapeutic target for HCC.